文献速递乳腺技术与安全CT

锥形束乳腺CT影像组学预测乳腺癌腋窝淋巴结转移:多中心多设备研究

Radiomics in cone-beam breast CT for the prediction of axillary lymph node metastasis in breast cancer: a multi-center multi-device study.
PubMed 文献 · Eur Radiol · 2023-10-02

本研究基于两个机构、两种扫描仪的274例增强锥形束乳腺CT图像,从原发肿瘤提取1781个影像组学特征构建支持向量机模型,术前预测腋窝淋巴结状态及转移负荷。影像组学模型预测N0与N+(≥1)的AUC为0.75±0.05,优于临床模型0.68±0.07(p<0.01),与联合模型0.74±0.05无显著差异(p=0.56);预测转移负荷的AUC为0.65±0.10,范围跨越0.5。

要点

  • 增强锥形束乳腺CT原发肿瘤影像组学可术前预测腋窝淋巴结状态,AUC 0.75±0.05,优于临床模型。
  • 预测淋巴结转移负荷(N+1~2 vs N+≥3)能力有限,AUC 0.65±0.10,所有重复范围均跨越0.5。
  • 影像组学特征描述肿瘤纹理,腋窝淋巴结阳性肿瘤异质性更高。

核心结论

  • 原发肿瘤的影像组学特征在增强锥形束乳腺CT上可能有助于预测腋窝淋巴结转移,并可能弥补锥形束乳腺CT腋窝覆盖有限的不足。

研究设计与样本

  • 多中心多设备研究,纳入2012至2021年两个机构、两种扫描仪的274例增强锥形束乳腺CT检查患者,以组织病理学为参考标准。

关键影像表现/征象

  • 从每位患者原发肿瘤标注中提取1781个影像组学特征,经特征选择后构建支持向量机模型。
  • 描述肿瘤纹理的影像组学特征对腋窝淋巴结状态有信息价值,腋窝淋巴结阳性肿瘤异质性更高。

诊断标准与关键数值

  • 预测腋窝淋巴结状态(N0/N+≥1):影像组学模型AUC 0.75±0.05(范围0.67~0.93),临床模型0.68±0.07(0.53~0.85),联合模型0.74±0.05(0.67~0.88)。
  • 预测转移负荷(N+1~2/N+≥3):影像组学模型AUC 0.65±0.10(0.50~0.88),临床模型0.55±0.10(0.40~0.80),联合模型0.64±0.09(0.50~0.90),所有范围均跨越0.5。
  • 影像组学模型在两项任务中均显著优于临床模型(均p<0.01),与联合模型无显著差异(p=0.56和0.64)。

临床应用与阅片要点

  • 增强锥形束乳腺CT影像组学模型可能用于术前预测腋窝淋巴结状态(N0 vs N+≥1)。
  • 对转移负荷(N+1~2 vs N+≥3)的预测能力有限,所有AUC范围均跨越0.5。
  • 未来需在更大队列中验证。

局限性

  • 原文指出预测转移负荷的能力有限,所有AUC范围均跨越0.5。
  • 原文指出需在未来更大队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop a radiomics model in contrast-enhanced cone-beam breast CT (CE-CBBCT) for preoperative prediction of axillary lymph node (ALN) status and metastatic burden of breast cancer.

METHODS: Two hundred and seventy-four patients who underwent CE-CBBCT examination with two scanners between 2012 and 2021 from two institutions were enrolled. The primary tumor was annotated in each patient image, from which 1781 radiomics features were extracted with PyRadiomics. After feature selection, support vector machine models were developed to predict ALN status and metastatic burden. To avoid overfitting on a specific patient subset, 100 randomly stratified splits were made to assign the patients to either training/fine-tuning or test set. Area under the receiver operating characteristic curve (AUC) of these radiomics models was compared to those obtained when training the models only with clinical features and combined clinical-radiomics descriptors. Ground truth was established by histopathology.

RESULTS: One hundred and eighteen patients had ALN metastasis (N + (≥ 1)). Of these, 74 had low burden (N + (1~2)) and 44 high burden (N + (≥ 3)). The remaining 156 patients had none (N0). AUC values across the 100 test repeats in predicting ALN status (N0/N + (≥ 1)) were 0.75 ± 0.05 (0.67~0.93, radiomics model), 0.68 ± 0.07 (0.53~0.85, clinical model), and 0.74 ± 0.05 (0.67~0.88, combined model). For metastatic burden prediction (N + (1~2)/N + (≥ 3)), AUC values were 0.65 ± 0.10 (0.50~0.88, radiomics model), 0.55 ± 0.10 (0.40~0.80, clinical model), and 0.64 ± 0.09 (0.50~0.90, combined model), with all the ranges spanning 0.5. In both cases, the radiomics model was significantly better than the clinical model (both p < 0.01) and comparable with the combined model (p = 0.56 and 0.64).

CONCLUSIONS: Radiomics features of primary tumors could have potential in predicting ALN metastasis in CE-CBBCT imaging.

CLINICAL RELEVANCE STATEMENT: The findings support potential clinical use of radiomics for predicting axillary lymph node metastasis in breast cancer patients and addressing the limited axilla coverage of cone-beam breast CT.

KEY POINTS: • Contrast-enhanced cone-beam breast CT-based radiomics could have potential to predict N0 vs. N + (≥ 1) and, to a limited extent, N + (1~2) vs. N + (≥ 3) from primary tumor, and this could help address the limited axilla coverage, pending future verifications on larger cohorts. • The average AUC of radiomics and combined models was significantly higher than that of clinical models but showed no significant difference between themselves. • Radiomics features descriptive of tumor texture were found informative on axillary lymph node status, highlighting a higher heterogeneity for tumor with positive axillary lymph node.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu Y, Ma Y, Zhai Z, et al. Radiomics in cone-beam breast CT for the prediction of axillary lymph node metastasis in breast cancer: a multi-center multi-device study. Eur Radiol. 2023. PMID: 37782338. doi:10.1007/s00330-023-10256-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。